New PBC and NASH Data to be Presented at AASLD’s The Liver Meeting Digital Experience™
Presentation of long-term efficacy and safety data of obeticholic acid (OCA) for the treatment of patients with PBCAnalysis from Phase 3 REGENERATE study examines the antifibrotic efficacy of OCA on noninvasive measures of liver fibrosis in patients with fibrosis due to NASH NEW YORK, Oct. 29, 2020 (

Full story is loading. Click here if it doesn't...

Advertisement